Please assess the completion status of the following clinical trial:

Trial Title: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologic diagnosis of squamous cell carcinoma of esophagus. Preoperative stage Ⅱ-Ⅲ by endoscopic ultrasound, CT of the chest and abdomen,and esophagogram.~* Age ranges from 18 to 70 years.~* Patients must not have received any prior anticancer therapy.~* Performance status of 0 to 1~* Estimated life expectancy of at least 6 months.~* Tumor can be measured according to RECIST criteria~* Signed informed consent document on file.~* Females with childbearing potential must have a negative serum pregnancy~* Adequate organ function including the following:~Bone marrow: Absolute neutrophil count (ANC) greater than or equal 1.5×109/L Platelets greater than or equal 80×109/L Haemoglobin greater than or equal 80g/L Hepatic: total bilirubin less than or equal to 1.5 times upper limit of normal (ULN), Alanine transaminase (ALT) and aspartate transaminase (AST) less than or equal to 2.5 times ULN Renal: calculated creatinine clearance rate≥60ml/min. test within 7 days prior to study enrollment.~Exclusion Criteria:~* Carcinoma at the upper part of esophagus~* Histologic diagnosis of adenocarcinoma of esophagus.~* Prior treatment for esophageal cancer.~* Active infection.~* Pregnant or breast feeding.~* History of significant neurological or mental disorder, including seizures or dementia.~* Prior invasive malignancy in 5 years (except for carcinoma in situ).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- nab-paclitaxel plus cisplatin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).